Antibiotic Resistance: Current Perspectives.

Area of Science:

• Microbiology
• Drug Discovery
• Molecular Biology

Background:

• Antibiotic resistance poses a critical global health challenge, with increasing mortality from drug-resistant infections.
• Existing antibiotics primarily target essential central dogma pathways, but bacteria develop resistance through evolved survival mechanisms.
• There is an urgent need to explore novel therapeutic targets beyond traditional pathways.

Purpose of the Study:

• To highlight the potential of targeting auxiliary pathways, specifically metabolism-related and stress-associated pathways, for new antibiotic development.
• To discuss the stringent response pathway, regulated by guanosine tetraphosphate/guanosine pentaphosphate ((p)ppGpp), as a promising target for combating bacterial persistence.
• To review recent advancements in small molecule analogues of (p)ppGpp and other strategies for inhibiting bacterial growth and biofilms.

Main Methods:

• Review of recent literature on small molecule analogues of (p)ppGpp.
• Exploration of targeting strategies including small RNAs, riboswitches, and antimicrobial peptides.
• Analysis of the stringent response pathway's role in bacterial survival and virulence.

Main Results:

• Small molecule analogues of (p)ppGpp have demonstrated promising results in inhibiting bacterial growth and biofilm formation.
• Inhibition of the stringent response pathway can reduce the persistence and long-term survival of pathogenic bacteria.
• Emerging strategies like targeting small RNAs, riboswitches, and antimicrobial peptides offer future avenues for combating drug resistance.

Conclusions:

• The stringent response pathway represents a viable target for developing novel antibacterial agents.
• Small molecules targeting (p)ppGpp and related pathways hold significant therapeutic potential.
• A multi-pronged approach, including small RNAs, riboswitches, and antimicrobial peptides, is crucial for overcoming antibiotic resistance.